Scarica l'app Stockscreener
36.70
1.50%
-0.56
Dopo l'orario di chiusura:
36.70
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$37.26
Aprire:
$36.69
Volume 24 ore:
1.47M
Relative Volume:
0.62
Capitalizzazione di mercato:
$5.56B
Reddito:
$3.24B
Utile/perdita netta:
$304.90M
Rapporto P/E:
17.64
EPS:
2.08
Flusso di cassa netto:
$156.70M
1 W Prestazione:
+3.38%
1M Prestazione:
-7.88%
6M Prestazione:
-36.67%
1 anno Prestazione:
-44.00%
Intervallo 1D:
$36.01
$37.27
Intervallo di 1 settimana:
$36.01
$37.97
Portata 52W:
$34.10
$72.94
Bruker Corp Stock (BRKR) Company Profile
Nome
Bruker Corp
Settore
Industria
Telefono
978663-3660
Indirizzo
40 MANNING RD, BILLERICA, MA
Confronta BRKR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
36.70 | 5.38B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-10 | Iniziato | UBS | Neutral |
| 2024-12-05 | Aggiornamento | Goldman | Sell → Neutral |
| 2024-10-15 | Iniziato | Barclays | Overweight |
| 2024-09-30 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-02-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2022-10-21 | Iniziato | UBS | Buy |
| 2022-08-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Iniziato | Goldman | Sell |
| 2020-11-16 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Downgrade | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Downgrade | Needham | Strong Buy → Hold |
| 2020-03-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2019-06-24 | Reiterato | Needham | Strong Buy |
| 2019-06-21 | Reiterato | BofA/Merrill | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
| 2019-05-06 | Reiterato | Needham | Strong Buy |
| 2019-05-03 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Aggiornamento | UBS | Sell → Neutral |
| 2019-04-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Reiterato | BTIG Research | Buy |
| 2019-01-03 | Iniziato | Needham | Strong Buy |
Mostra tutto
Bruker Corp Borsa (BRKR) Ultime notizie
Bruker Corporation to Present at the Jefferies Global Healthcare Conference - Yahoo
Bruker (BRKR) Introduces Advanced Mass Spectrometry System | BRK - GuruFocus
Bruker launches timsOmni system for advanced proteomics - Investing.com
Bruker Launches Revolutionary timsOmniTM Mass Spectrometer - Yahoo Finance
Bruker (BRKR) Unveils Advanced 4D-Metabolomics System | BRKR Stock News - GuruFocus
Bruker unveils new timsMetabo system for metabolomics - Investing.com
Bruker Launches Novel timsMetabo™ Mass Spectrometer for Breakthrough 4D-Metabolomics and 4D-Lipidomics Sensitivity, Specificity and Annotation Confidenceat Speed, Depth, and Scale - Yahoo Finance
Bruker Stock to Gain From the Launch of MOVE-T Liquid Dairy Analyzer - Yahoo Finance
Bruker Corp: Pan-Omics Dominance At A Margin Inflection Point (BRKR) - Seeking Alpha
Bruker launches MOVE-T for dairy quality control - Investing.com
Bruker Introduces Novel MOVE-T System for Transferable, Robust Milk and Liquid Dairy Analysis with FT-NIR Technology - Quantisnow
Bruker Corp (BRKR) Shares Up 4.51% on May 27 - GuruFocus
Bruker (BRKR) Downgraded by Citigroup with Price Target Lowered to $40 | BRKR Stock News - GuruFocus
Expert Outlook: Bruker Through The Eyes Of 8 Analysts - Benzinga
This Guidewire Software Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
Citi cuts Bruker stock rating, lowers price target to $40 - Investing.com
Bruker (BRKR) Downgraded to Neutral by Citi with $40 Price Target | BRKR Stock News - GuruFocus
Bruker Corp (BRKR) Shares Down 3.3% on May 21 - GuruFocus
Benchtop Optofluidic System | Bruker Nano Surfaces | Products - Photonics Spectra
Bruker (BRKR) Shows Positive Signals Post-Settlement | BRKR Stock News - GuruFocus
July 18th Options Now Available For Bruker (BRKR) - Nasdaq
Bruker (BRKR) and 10x Genomics Resolve Global Patent Dispute | B - GuruFocus
Bruker (BRKR) and 10x Genomics Settle Patent Disputes Globally - GuruFocus
Bruker Sets Next Dividend Payment: $0.05 Per Share Coming June 27Key Dates Inside - Stock Titan
10x Genomics settles patent dispute with Bruker for $68 million By Investing.com - Investing.com Canada
10x Genomics settles patent dispute with Bruker for $68 million - Investing.com
10x Genomics Announces Patent Litigation Settlement Agreement with Bruker - Financial Times
Bruker and 10x Genomics settle patent dispute - Yahoo Finance
Two Photon Microscope | Bruker Nano Surfaces | Products - Photonics Spectra
Bruker (BRKR) and 10x Genomics Settle Patent Dispute with Cross-License Agreement | BRKR Stock News - GuruFocus
Investors Can Find Comfort In Bruker's (NASDAQ:BRKR) Earnings Quality - Yahoo Finance
Major Patent Battle Ends: Bruker and 10x Genomics Strike Global Deal to Protect Spatial Biology Innovation - Stock Titan
10x Genomics, Bruker Strike Deal After $31M Patent Verdict - Law360
10x, Bruker End Patent Suit on NanoString Gene-Mapping Tools (1) - Bloomberg Law News
Bruker Corporation (BRKR) Declined Amid NIH Funding and Tariff Uncertainty - Yahoo Finance
International Markets and Bruker (BRKR): A Deep Dive for Investors - Yahoo Finance
Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know - Yahoo Finance
Bruker Corporation (BRKR): Among Michael Burry Stocks with Huge Upside Potential - Insider Monkey
Bruker Corporation (BRKR): A Bull Case Theory - MSN
Bruker Corporation (NASDAQ:BRKR) Q1 2025 Earnings Call Transcript - Insider Monkey
Stifel cuts Bruker stock price target to $48, maintains hold By Investing.com - Investing.com Canada
Bruker (BRKR) Sees Price Target Lowered to $45 by UBS | BRKR Sto - GuruFocus
Bruker (BRKR) Sees Price Target Lowered to $45 by UBS | BRKR Stock News - GuruFocus
Bruker (BRKR): Barclays Maintains Rating but Lowers Price Target | BRKR Stock News - GuruFocus
Bruker (BRKR) Target Price Lowered by Goldman Sachs | BRKR Stock News - GuruFocus
Stifel cuts Bruker stock price target to $48, maintains hold - Investing.com
Bruker (BRKR) Stock Target Price Lowered by Stifel Analyst | BRK - GuruFocus
UBS Reduces Price Target for Bruker (BRKR) Amid Funding and Tariff Concerns | BRKR Stock News - GuruFocus
Bruker (BRKR) Stock Target Price Lowered by Stifel Analyst | BRKR Stock News - GuruFocus
Bruker (BRKR) Price Target Reduced by Stifel Amid Flat Growth Outlook | BRKR Stock News - GuruFocus
Bruker Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Crash - Nasdaq
Bruker Corp Azioni (BRKR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):